Manus Neurodynamica
Manufacturing · United Kingdom · 1-10 Employees
View Company Info for Free
Overview
Headquarters
12 Alva St, Edinburgh, Midlothian, EH2 4...Phone Number
+44 1315635465Website
www.manusneuro.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Manus Neurodynamica
MANUS Neurodynamica's mission is to develop and market new medical technologies with niches in the management of neuromotor diseases in the clinical and home environment to; improve the lives of patients suffering from such impairments, improve efficiency of healthcare and reduce healthcare costs. MANUS envisions a range of novel biomedical instrumentation with applications in diagnostics, rehabilitation and patient monitoring. Manus was registered in 2008 and since then, the continued technical development focussed on specific applications in clinical settings, such as diagnosing PD, rehabilitation and training of upper limb function and has developed unique technologies to reliably perform non-invasive recordings and analyses of the human motion control mechanisms.Explore more
Manus Neurodynamica Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Manus Neurodynamica your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Manus Neurodynamica launches new products
Congratulate Masked Content for being promoted to Masked Content at Manus Neurodynamica
Click to see if Manus Neurodynamica had a recent Job posting/layoffs
Check out if Manus Neurodynamica is spiking on competitors!
Manus Neurodynamica, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Check if Manus Neurodynamica has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Manus Neurodynamica recently announced quarterly report
Funding: Get notified immidiatlly once Manus Neurodynamica has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at Manus Neurodynamica
Find more new buyers
Compare Similar Companies to Manus Neurodynamica
Compare insights from companies similar to Manus Neurodynamica, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Manus Neurodynamica is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Manus Neurodynamica is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Manus Neurodynamica.
Manus Neurodynamica financials insights
Gather financial insights about Manus Neurodynamica, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Unspecified
$1.6M
Manus Neurodynamica Tech Stack
A closer look at the technologies used by Manus Neurodynamica
See more technologies
Manus Neurodynamica News & Media
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Manus Neurodynamica
Sign Up For FreeTo access detailed company insights
MANUS Neurodynamica's mission is to develop and market new medical technologies with niches in the management of neuromotor diseases in the clinical and home environment to; improve the lives of patients suffering from such impairments, improve efficiency of healthcare and reduce healthcare costs. MANUS envisions a range of novel biomedical instrum... Read More
